Tesamorelin +Ipamorelin + CJC-1295 without DAC (BLEND)
130,00$
Description
Tesamorelin + Ipamorelin + CJC-1295 (without DAC) is a multi-compound research blend classified as a growth hormone–modulating peptide combination, designed to study endogenous GH secretion, pulsatility, and downstream metabolic signaling. This blend combines:
- Tesamorelin (6 mg) – a stabilized GHRH analog
- CJC-1295 without DAC (3 mg) – a short-acting GHRH analog
- Ipamorelin (3 mg) – a selective growth hormone secretagogue (GHS-R agonist)
Together, these compounds are used in laboratory research to investigate synergistic stimulation of growth hormone release, mimicking both hypothalamic and ghrelin-mediated pathways. Epigenetix Labs supplies this GH research blend for laboratory use only, intended exclusively for qualified professionals conducting in vitro or preclinical investigations. This product is strictly for research use only. Not for human or veterinary use. Researchers sourcing this growth hormone peptide blend for research utilize it to study endocrine regulation, metabolic signaling, and body composition pathways.
10 Research-Based Reasons to Study
- Stimulates endogenous growth hormone via dual pathways
- Enhances GH pulsatility in research models
- Activates both GHRH and ghrelin receptor signaling
- Supports IGF-1 pathway investigation
- Enables study of endocrine feedback mechanisms
- Used in metabolic and fat distribution research
- Facilitates investigation of anabolic signaling pathways
- Demonstrates synergistic GH release effects
- Valuable for aging-related GH decline models
- Reference combination in GH-axis research
Additional information
Additional information
| Weight | 0,006 kg |
|---|---|
| Dimensions | 1,5 × 1,5 × 3,5 cm |
| Research Applications | This peptide blend is frequently utilized in laboratory research involving: • Endocrine system regulation This makes it a core compound within advanced laboratory peptides and growth hormone research portfolios. |
| Key Research Findings | Preclinical and clinical research has demonstrated that: • GHRH analogs increase endogenous GH secretion and IGF-1 levels |
| Scientific Background | This blend is designed to activate the two primary pathways that regulate endogenous growth hormone secretion, creating a more complete and physiologically relevant model of GH-axis activity. Tesamorelin and CJC-1295 (without DAC) stimulate the anterior pituitary via GHRH receptors, supporting natural pulsatile growth hormone release and downstream IGF-1 signaling. In parallel, Ipamorelin activates the ghrelin receptor (GHS-R1a), providing an additional, independent stimulus for growth hormone secretion without significant interaction with cortisol or prolactin pathways. By combining these complementary mechanisms, the blend enables researchers to study synergistic GH release and offers a comprehensive framework for investigating growth hormone pulsatility, endocrine feedback, IGF-1 signaling, and metabolic pathways. |
| Purity & Manufacturing Standards | Every batch of this blend from Epigenetix Labs is produced under strict analytical controls: • Manufactured using Solid-Phase Peptide Synthesis (SPPS) |
| Legal Disclaimer | This product is supplied strictly for qualified laboratory professionals conducting in vitro or preclinical research. Any therapeutic, diagnostic, or personal use is strictly prohibited. By purchasing this compound, you acknowledge that this peptide blend from Epigenetix Labs is intended solely as a research chemical. |
| Size | 12 mg |
Reviews (0)
Be the first to review “Tesamorelin +Ipamorelin + CJC-1295 without DAC (BLEND)”
Related products
-
-
Select options This product has multiple variants. The options may be chosen on the product page
-
-
Reviews
There are no reviews yet.